Pseudomyxoma peritonei

Clinical Oncology

Volumn 15, Issue 2, 2003, Pages 73-77

  Harshen, R ^a   Jyothirmayi, R ^b   Mithal, N ^c  

^a EPSOM GENERAL HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Intraperitoneal chemotherapy; Mucinous ascites; Pseudomyxoma peritonei

Indexed keywords

ALTRETAMINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN C;

APPENDIX; ARTICLE; BONE MARROW SUPPRESSION; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ECHOGRAPHY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; LAPAROTOMY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM PSEUDOMYXOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0037378961     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2002.0163     Document Type: Article

References (50)

1. Werth R. Klinische und anatomische Untersuchungen Zur Lehre Von den Bauchgeschwiilsten und der Laparotomie. Arch Gynaecol Obstet 1884;24:100-118.
2. Mann WJ, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990;66:1636-1640.
3. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Schmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Am J Surg Pathol 1995;19: 1390-1408.
4. Szych C, Staedler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 1999;154:1849-1855.
5. Young RH, Gilk CB, Scully RE. Mucinous tumours of the appendix associated with mucinous tumours of the ovary and pseudomyxoma peritonei. A clinicopathalogical analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991; 15:415-429.
6. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei: a clinicopathalogic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumours. Am J Surg Pathol 1994;18:591-603.
7. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathalogic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumours of low malignant potential. Hum Pathol 1995;26:509-524.
8. Seidman JD, El Sayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumours of the ovary and appendix. A clinicopathalogic study of 25 cases. Am J Surg Pathol 1993;17:22-34.
9. Ronnett BM, Schmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynaecol Pathol 1997;16:1-9.
10. Bree ED, Whitkamp A, Vande Vijver M, Zoetmulde F. Unusual origins of pseudomyxoma peritonei. J Surg Oncol 2000;75: 270-274.
11. Sherer DM, Abulafia O, Elia Kim R. Pseudomyxoma peritonei: A review of current literature. Gynaecol Obstet Invest 2001;51:73-80.
12. Jackson SL, Fleming RA, Loggie BW, Geisinger KR. Gelatinous ascitis: A cytohistological study of pseudomyxoma peritonei in 67 patients. Mod Pathol 2001;14:664-671.
13. Hinson FL, Ambrose NS. Pseudomyxoma Peritonei Br J Surg 1988;85:1332-1339.
14. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000;87:1414-1418.
15. Sugarbaker PH. Pseudomyxoma peritonei: a cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 1994; 219:109-111.
16. Zoetmulder FA, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 1996;32A:1727-1733.
17. Yaqoob M, Fihal IH, Finn R. Obstructive nephropathy due to pseudomyxoma peritonei and its management by cystic obliteration and urinary diversion. Nephrol Dial Transplant 1991;6:60-61.
18. Walensky RP, Venbrux AC, Prescott CA, Osterman FA Jr. Pseudomyxoma peritonei. AJR Am J Roentgenol 1996;167: 471-474.
19. Tsaic J. Ultrasound features of disseminated adenomucinosis (pseudomyxoma). Br J Radiol 1998;71:564-566.
20. Bechtold RE, Chen MY, Loggie BW, Jackson SL, Geisinger K. CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 2001;26:406-410.
21. Matsumi H, Kozuma S, Osuga Y, et al. Ultrasound imaging of pseudomyxoma peritonei with numerous vesicles in ascitic fluid. Ultrasound Obstet Gynecol 1999;13:378-379.
22. Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 1989;9:115-118.
23. Friedland JS, Allardice JT, Wyatt AP. Pseudomyxoma peritonei. J R Soc Med 1986;79:480-482.
24. Sudhindran S, Varghese CJ, Ramesh H. Pseudomyxoma peritonei: a case report of 8 cases. Indian J Gasteroenterol 1994;13:137-138.
25. Sugarbaker PH. Pseudomyxoma peritonei. Cancer Treat Res 1996;81:105-119.
26. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Goff BA. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 1994;84:17-21.
27. Sugarbaker PH, Zhu BW, Banez Sese G, Schmookler B. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323-329.
28. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239-243.
29. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Longterm patient survival with an aggressive regional approach. Ann Surg 1994;219:112-119.
30. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma of appendiceal origin. The Memorial Sloan-Kettering Cancer Centre Experience. Cancer 1992;70:396-401.
31. Raj J, Urban LM, ReMine SG, Raj PK. Laparoscopic management of pseudomyxoma peritonei secondary to adenocarcinoma of the appendix. J Laparoendosc Adv Surg Tech 1999;9:299-303.
32. Keating JP, Frizelle FA. Use of ultrasonic surgical aspirator in the operative cytoreduction of pseudomyxoma peritonei. Dis Colon Rectum 2000;43:559-560.
33. Look KY, Stehman FB, Moore DH, Sutton GP. Intraperitoneal 5FU for pseudomyxoma peritonei. Int J Gynaecol Cancer 1995;5: 361-365.
34. Shiraishi S, Sakurai N, Tanaka Y, Iwahashi K, Kitaoka Y. A case study of pseudomyxoma peritonei treated successfully with intraperitoneal administration of CBDCA and etoposide, followed by local delivery of dextran with CDDP during surgery. Gan To Kagaku Ryoho 2001;28:1155-1157.
35. Hosch WP, Rudi J, Stremmel W. Therapy of pseudomyxoma peritonei of appendiceal origin - surgical resection and intraperitoneal chemotherapy. Z Gastro Enterol 1999;37:615-622.
36. Nasr MF, Kemp GM, Given FT Jr. Peudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil. Eur J Gynaecol Oncol 1993;14:213-217.
37. Ohta Y, Shima Y, Sasaki N, Nishida T, Yamayoshi T, Adachi A. Successful treatment of pseudomyxoma peritonei using combination chemotherapy of intraperitoneal low-dose CDDP and oral 5′-DFUR administration. Gan To Kagaku Ryoho 1998;25:929-932.
38. Witkamp AJ, DeBree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88: 458-463.
39. Vocelka CR, Anderson DL, Crockett GI. Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two pump system: a case report. Perfusion 2000;15:549-552.
40. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the invitro cytotoxicity of Mitomycin C towards hypoxic tumour cells. Cancer Res 1981;41:1096-1099.
41. El Sayed S. Pseudomyxoma peritonei treated by radiotherapy. Clin Oncol 1990;2:120-122.
42. Fernandez RN, Daly JM. Pseudomyxoma peritonei. Arch Surg 1980;115:409-414.
43. Laitinen JO, Kairemo KJA, Jekunen AP, Korppi-Tommola T, Tenhunen M. The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma. Cancer 1997;80: 2545-2552.
44. Mohlen K, Beller FK. Pseudomyxoma peritonei. Effect of radio gold therapy. Zentralbl Gynakol 1979;100:1408-1411.
45. FuKuma K, Matsuura K, Shibata S, Nakahara K, Fujisaki S, Maeyama M. Pseudomyxoma peritonei: effect of chronic continuous immunotherapy with a streptococcal preparation, OK-432 after surgery. Acta Obstet Gynecol Scand 1986;65:133-137.
46. Piver MS, Lele SB, Patsner B. Pseudomyxoma peritonei: possible prevention of mucinous ascitis by peritoneal lavage. Obstet Gynaecol 1984;64:95-96.
47. Roy WJ Jr, Thomas BE, Horowitz IR. Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxoma peritonei. Gynaecol Oncol 1997;65:360-362.
48. Sindelar WF, DeLaney TF, Tochner Z, Thomas GF, Dachoswki LJ, Smith PD. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch Surg 1991;126:318-324.
49. Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumours of borderline malignancy. Gynaecol Oncol 1990;39:195-198.
50. Costa MJ. Pseudomyxoma peritonei: histological predictors of patient survival. Arch Pathol Lab Med 1994;118:1215-1219.